Indicator Ventures turns 10! Check out our hype video—it's 🔥 None of this would be possible without our LPs and the amazing founders who’ve allowed us to share in their journeys. Justin Donovan, Conner Sherline, Nikita Bier, Jacob Donoghue, MD PhD, Michael Healander & Daniel Bradshaw, Aaron Bai & Sahil Phadnis, Toni Oloko & Daniel Hanover, Jessica Nam Kim & Steven Lee, Leore Avidar, Christina Qi, Bill Gianoukos, Adam Nathan, Puneet Mehta, Santosh Patel, Jessica Powell, Cat Noone, Saurav Shroff, Zeeshan Zia, Mike Meyers, Arianna Armelli, George S., Birago Jones & Karthik Dinakar, Andrew Cohen, Peter Morris, Yasir Ali, Drew Austin, Shane Scranton & Nate Beatty, Adam Gomolin, Adam Freund, Bob Nahmias & Jason Bobby, Joseph Galarneau, Umaimah Mendhro, and more!

I'm thrilled to share that Databento has successfully raised an additional $10 million in funding, bringing our total Series A to $30 million. It's not just the funding—it's the support and trust from our partners, old and new, that makes this achievement truly special. Having Belvedere Trading, LLC, Clear Street, Lightscape Partners, and so many prominent asset managers on board reflects a powerful, industry-wide belief in Databento's mission. Thank you to Redpoint, Good Growth Capital, Blindspot Ventures, Trousdale Ventures, Indicator Ventures, Unusual Ventures, 2 | Twelve and all of our investors for your unwavering support since Day 0. This milestone would not have been possible without our community of customers and supporters. You don't owe us anything. And yet you introduced me to investors, served as a reference, and provided encouragement during a challenging fundraising environment. I owe this round to you. This fundraise was a company-wide effort, with enormous help from all of my teammates. You're the reason why we've made it this far today, in only 1.5 years since we launched Databento together. Philosophically: Funding is not a reflection of our self-worth. It's one of many optional paths than a startup can take, in the hopes of accelerating our growth trajectory. Your career path is unique: success will mean something different to you, and that's okay. I'm incredibly proud to work with our amazing team at Databento, and grateful for the opportunity to keep building something meaningful for our users. Here's to leading a new era in market data together! 🎉

Arda is pleased to announce the closing of our $43M Series A financing to accelerate the development of precision cell-depleting biologics to treat chronic diseases. The new capital will be used to drive our existing I&I pipeline toward the clinic, expand into new indications, and scale our single cell discovery platform. Thank you to our investors Andreessen Horowitz, Two Sigma Ventures, RV Invest, Eli Lilly and Company, GV (Google Ventures), Biovision Ventures, Valhalla Ventures, Indicator Ventures, Alumni Ventures, LifeLink Ventures, Mana Ventures, Gaingels, and Exitfund. Learn more about our mission to deplete pathogenic cells to treat disease at www.ardatx.com!